FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2624304891> ?p ?o ?g. }

• W2624304891 endingPage "48" @default.
• W2624304891 startingPage "40" @default.
• W2624304891 abstract "Background Anti-double stranded DNA antibodies are a very heterogeneous group of antibodies, quite specific for systemic lupus erythematosus. Newer technologies, such as addressable laser bead immunoassays (ALBIA), show great potential as a diagnostic application. The production of anti-double stranded DNA antibodies is often encountered in inflammatory arthritis; however, literature reports that the actual onset of drug induced lupus in patients treated with biological drugs is a rare event. False positive results for anti-double stranded DNA and anti-nucleosome antibodies detected in patients with inflammatory arthritis treated with different biologics prompted the investigation of full autoantibody profiles to evaluate each biomarker’s diagnostic performance in systemic lupus erythematosus. The aim of the study was to compare the diagnostic performance of anti-double stranded DNA antibody and anti-nucleosome antibody methods and to evaluate the value of simultaneously measuring anti-double stranded DNA and anti-nucleosome antibodies, along with other anti-nuclear antibody analytes, as biomarkers for systemic lupus erythematosus, using a more appropriate control cohort including inflammatory arthritis patients with a non-clinical drug induced lupus. Methods Anti-double stranded DNA and anti-nucleosome antibody levels were evaluated in 247 patient samples: 70 systemic lupus erythematosus, 177 disease controls (including 97 inflammatory arthritis during treatment with different biologics) using the Bio-Rad BioPlex® 2200. Results Anti-nucleosome antibodies demonstrated greater clinical sensitivity and specificity than anti-double stranded DNA antibodies. At the manufacturers’ cut-off range, considering the two markers as a single or combined test, the “anti-double stranded DNA test or anti-nucleosome antibodies” was the most sensitive combination (0.400) with the best negative likelihood ratio (0.62) and negative predictive value (0.803). Conclusion Anti-nucleosome antibodies are a more sensitive and specific biomarker of systemic lupus erythematosus than anti-double stranded DNA antibodies. Anti-nucleosome antibodies and anti-double stranded DNA antibodies are independent and complementary markers of systemic lupus erythematosus diagnosis and, therefore, are strongly suggested as combined tests (positive predictive value = 0.938). Moreover, the combined use of the two tests may help to overcome the decreased specificity percentage of the anti-double stranded DNA test, when considering an inflammatory arthritis cohort under biological therapies. The ALBIA method for anti-nuclear specificity detection allows a full autoantibody assessment, resulting in a much higher clinical specificity for systemic lupus erythematosus in the presence of ≥3 positive markers and significantly more positive likelihood ratio when ≥2 positive markers are present." @default.
• W2624304891 created "2017-06-15" @default.
• W2624304891 creator A5019462333 @default.
• W2624304891 creator A5038039241 @default.
• W2624304891 creator A5053318866 @default.
• W2624304891 creator A5053922189 @default.
• W2624304891 creator A5074722507 @default.
• W2624304891 creator A5077549022 @default.
• W2624304891 date "2017-06-06" @default.
• W2624304891 modified "2023-09-24" @default.
• W2624304891 title "The impact of biological treatments on the anti-dsDNA and anti-nucleosome tests" @default.
• W2624304891 cites W1527171042 @default.
• W2624304891 cites W1543381911 @default.
• W2624304891 cites W1759851510 @default.
• W2624304891 cites W1971059031 @default.
• W2624304891 cites W1974492781 @default.
• W2624304891 cites W1989256666 @default.
• W2624304891 cites W1991963925 @default.
• W2624304891 cites W1996182613 @default.
• W2624304891 cites W1999487704 @default.
• W2624304891 cites W2001500757 @default.
• W2624304891 cites W2001556703 @default.
• W2624304891 cites W2001574120 @default.
• W2624304891 cites W2003274865 @default.
• W2624304891 cites W2003884736 @default.
• W2624304891 cites W2008321895 @default.
• W2624304891 cites W2024119587 @default.
• W2624304891 cites W2024374472 @default.
• W2624304891 cites W2024901382 @default.
• W2624304891 cites W2025703181 @default.
• W2624304891 cites W2041087331 @default.
• W2624304891 cites W2046076469 @default.
• W2624304891 cites W2046414476 @default.
• W2624304891 cites W2054330426 @default.
• W2624304891 cites W2059200923 @default.
• W2624304891 cites W2070527591 @default.
• W2624304891 cites W2071998092 @default.
• W2624304891 cites W207238528 @default.
• W2624304891 cites W2077358378 @default.
• W2624304891 cites W2078610240 @default.
• W2624304891 cites W2089584055 @default.
• W2624304891 cites W2090488210 @default.
• W2624304891 cites W2093106492 @default.
• W2624304891 cites W2094313417 @default.
• W2624304891 cites W2098814276 @default.
• W2624304891 cites W2103925361 @default.
• W2624304891 cites W2104125890 @default.
• W2624304891 cites W2115037381 @default.
• W2624304891 cites W2123667712 @default.
• W2624304891 cites W2144414370 @default.
• W2624304891 cites W2144792857 @default.
• W2624304891 cites W2146203649 @default.
• W2624304891 cites W2159860161 @default.
• W2624304891 cites W2172048715 @default.
• W2624304891 cites W2317716371 @default.
• W2624304891 cites W4210300432 @default.
• W2624304891 cites W4252776428 @default.
• W2624304891 doi "https://doi.org/10.1177/0961203317709344" @default.
• W2624304891 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28587585" @default.
• W2624304891 hasPublicationYear "2017" @default.
• W2624304891 type Work @default.
• W2624304891 sameAs 2624304891 @default.
• W2624304891 citedByCount "5" @default.
• W2624304891 countsByYear W26243048912018 @default.
• W2624304891 countsByYear W26243048912019 @default.
• W2624304891 countsByYear W26243048912020 @default.
• W2624304891 countsByYear W26243048912022 @default.
• W2624304891 crossrefType "journal-article" @default.
• W2624304891 hasAuthorship W2624304891A5019462333 @default.
• W2624304891 hasAuthorship W2624304891A5038039241 @default.
• W2624304891 hasAuthorship W2624304891A5053318866 @default.
• W2624304891 hasAuthorship W2624304891A5053922189 @default.
• W2624304891 hasAuthorship W2624304891A5074722507 @default.
• W2624304891 hasAuthorship W2624304891A5077549022 @default.
• W2624304891 hasBestOaLocation W26243048911 @default.
• W2624304891 hasConcept C126322002 @default.
• W2624304891 hasConcept C149443304 @default.
• W2624304891 hasConcept C159654299 @default.
• W2624304891 hasConcept C163764329 @default.
• W2624304891 hasConcept C203014093 @default.
• W2624304891 hasConcept C2776912625 @default.
• W2624304891 hasConcept C2777077863 @default.
• W2624304891 hasConcept C2779134260 @default.
• W2624304891 hasConcept C2779912601 @default.
• W2624304891 hasConcept C2780380361 @default.
• W2624304891 hasConcept C2781197716 @default.
• W2624304891 hasConcept C3020215258 @default.
• W2624304891 hasConcept C54355233 @default.
• W2624304891 hasConcept C552990157 @default.
• W2624304891 hasConcept C64927066 @default.
• W2624304891 hasConcept C71924100 @default.
• W2624304891 hasConcept C84772758 @default.
• W2624304891 hasConcept C86803240 @default.
• W2624304891 hasConceptScore W2624304891C126322002 @default.
• W2624304891 hasConceptScore W2624304891C149443304 @default.
• W2624304891 hasConceptScore W2624304891C159654299 @default.
• W2624304891 hasConceptScore W2624304891C163764329 @default.
• W2624304891 hasConceptScore W2624304891C203014093 @default.

• next